Ex-vivo and in-vivo evaluation of nanostructured lipid carrier loaded with gemcitabine and paclitaxel in A549 lung cell for management of resistant cancers. Int. J. Pharm. Sci. Drug Res. [Internet]. 2021 Jul. 30 [cited 2025 Dec. 15];13(4):410-7. Available from: https://ijpsdronline.com/index.php/journal/article/view/3070